Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Journal of Breast Cancer
>
2009
>
12
>
3
Volume:
12
Issue:
3
1. Commentary on "The Number of Removed Lymph Nodes for an Acceptable False Negative Rate in Sentinel Node Biopsy for Breast Cancer".
Page:227—228
2. Malignant Peripheral Nerve Sheath Tumor of the Breast in a Patient without Neurofibromatosis: A Case Report.
Page:223—226
3. Malignant Adenomyoepithelioma of the Breast Presenting as a Large Mass that Grew Slowly without Metastasis.
Page:219—222
4. Metastasis of Non-Small Cell Lung Cancer to Ipsilateral Breast: A Case Report.
Page:215—218
5. Nationwide Survey of the Use of Absorbable Mesh in Breast Surgery in Korea.
Page:210—214
6. Depression and Coping in Breast Cancer Patients.
Page:199—209
7. Volume Replacement with Polyglactin 910 Mesh for Breast Reconstruction after Endoscopy-Assisted Breast Conserving Surgery for Treating Early Breast Cancer: the Early Results.
Page:193—198
8. The Safety and Cosmetic Effect of Immediate Latissimus Dorsi Flap Reconstruction after Breast Conserving Surgery.
Page:186—192
9. Preservation of Lymphatic Drainage of Arm during Axillary Procedure in Breast Cancer Patients.
Page:179—185
10. The Usefulness and Limitations of Intraoperative Frozen Section Analysis of Sentinel Lymph Nodes in Patients with Breast Cancer.
Page:170—178
11. Preoperative Axillary Staging Using 18F-FDG PET/CT and Ultrasonography in Breast Cancer Patients.
Page:163—169
12. The Clinical Significance of the Estrogen Receptor beta Expression for Endocrine Therapy in Patients with ERalpha-negative and Progesterone Receptor-positive Breast Carcinoma.
Page:156—162
13. The Use of Absorbable Surgical Mesh after Partial Mastectomy for Improving the Cosmetic Outcome.
Page:151—155
14. Additional Breast Ultrasound Examinations in Clustered Calcifications: for Improving Diagnostic Performance.
Page:142—150
15. Reactive Oxygen Species Generated by 17beta-estradiol Play a Role in the Up-regulation of GPX4 Protein in MCF-7 Breast Cancer Cells.
Page:134—141
16. MUC1 from the Mucin Family as Potential Tools in Breast Cancer Immunotherapy.
Page:125—133